Dudediligence.

Aspire Biopharma Holdings, Inc

ASBPNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1,941Sep ’25$4,261Dec ’25$28,353Mar ’26$63,104Jun ’26
Net income, by quarter
−$216,269Sep ’24−$765,710Dec ’24−$15.9MMar ’25−$2.0MJun ’25−$1.9MSep ’25−$4.7MDec ’25−$3.2MMar ’26−$1.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on filenone on filenone on filenone on file$6,202
Gross profitnone on filenone on filenone on filenone on file−$116.00
Operating incomenone on filenone on filenone on file−$1.2M−$19.4M
Net income−$25,475$3.3M$4.5M−$1.3M−$24.5M
Operating cash flow−$238,596−$1.4M−$653,107−$265,186−$4.9M
Cashnone on file$497,259$11,174$3,633$1.0M
Shares outstandingnone on filenone on filenone on file690.0K3.5M